Analyzing SSGI (OTCMKTS:VICP) & NVR (NYSE:NVR)

SSGI (OTCMKTS:VICP) and NVR (NYSE:NVR) are both construction companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, institutional ownership, valuation, earnings and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for SSGI and NVR, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SSGI	0	0	0	0	0.00
NVR	1	3	3	0	2.29

NVR has a consensus target price of $7,649.33, indicating a potential upside of 17.87%. Given NVR’s stronger consensus rating and higher possible upside, analysts clearly believe NVR is more favorable than SSGI.

Valuation & Earnings

This table compares SSGI and NVR”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SSGI	N/A	N/A	-$690,000.00	($0.04)	-36.50
NVR	$10.09 billion	1.74	$1.34 billion	$410.17	15.82

NVR has higher revenue and earnings than SSGI. SSGI is trading at a lower price-to-earnings ratio than NVR, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

83.7% of NVR shares are held by institutional investors. 6.0% of SSGI shares are held by company insiders. Comparatively, 8.6% of NVR shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares SSGI and NVR’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SSGI	N/A	N/A	N/A
NVR	12.93%	32.66%	21.16%

Volatility and Risk

SSGI has a beta of 4.45, indicating that its stock price is 345% more volatile than the S&P 500. Comparatively, NVR has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500.

Summary

NVR beats SSGI on 12 of the 13 factors compared between the two stocks.

About SSGI

Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product. The company’s product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia.

About NVR

NVR, Inc. operates as a homebuilder in the United States. The company operates through, Homebuilding and Mortgage Banking segments. It engages in the construction and sale of single-family detached homes, townhomes, and condominium buildings under the Ryan Homes, NVHomes, and Heartland Homes names. The company markets its Ryan Homes products to first-time and first-time move-up buyers; and NVHomes and Heartland Homes products to move-up and luxury buyers. It also provides various mortgage related services to its homebuilding customers, as well as brokers title insurance; performs title searches in connection with mortgage loan closings; and sells mortgage loans to investors in the secondary markets on a servicing released basis. The company primarily serves in Maryland, Virginia, West Virginia, Delaware, New Jersey, Eastern Pennsylvania, New York, Ohio, Western Pennsylvania, Indiana, Illinois, North Carolina, Georgia, South Carolina, Florida, Tennessee, and Washington, D.C. NVR, Inc. was founded in 1980 and is headquartered in Reston, Virginia.